Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

Sanofi’s $18.5bn bid for Genzyme rejected

August 31, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Sanofi-Aventis has gone public with its $18.5 billion offer for Genzyme after the US biotech’s board unanimously rejected the bid …
News

Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 2

August 26, 2010 Research and Development Kinapse, White paper, life sciences, pharma

With fierce competition in the market for late stage life sciences assets, pharmaceutical companies seeking partnering strategies to bolster pipelines …
Feature
White paper

Roche signs $1bn peptide deal with Aileron

August 25, 2010 Research and Development, Sales and Marketing Aileron, Roche, peptide, stapled peptide therapeutics

Roche has entered an agreement with a US biopharma company Aileron Therapeutics to develop and commercialise drugs called Stapled Peptide …
News

Sutent disappoints in lung cancer

August 24, 2010 Research and Development, Sales and Marketing NSCLC, Pfizer, Sutent, Tarceva

Pfizer’s Sutent has failed to improve overall survival in lung cancer patients when combined with Roche’s Tarceva. Pfizer’s SUN 1087 …
News

GSK shingles vaccine enters late stage trials

August 23, 2010 Research and Development, Sales and Marketing GSK, Vaccine, shingles

GlaxoSmithKline has started enrollment for phase III trials for its herpes zoster vaccine for the prevention of shingles. The trials …
News
Roche

Roche to acquire digital pathology specialists

August 23, 2010 Research and Development, Sales and Marketing Diagnostics, Roche

Roche has added to its portfolio of diagnostics products by acquiring US company BioImagene. The privately held Californian company specialises …
News
ASCO

ASCO 2010: The Hedgehog Pathway and other ways to target cancer

August 19, 2010 Research and Development ASCO, Cancer, thyroid cancer

The American Society of Clinical Oncology conference, one of the most important dates in the pharmaceutical industry’s calendar, took place …
Feature

Novartis and Quark sign gene silencing deal

August 19, 2010 Research and Development Novartis, Quark, SiRNA, rnai

Novartis has joined the race to develop a ‘gene silencing’ treatment by signing a new deal with siRNA specialist Quark …
News

Cell therapy industry partnership launched

August 18, 2010 Research and Development Genzyme, ISCT, Lonza, Roche

Pharma and biotech companies including Roche and Genzyme are to launch a series of initiatives to bolster progress in the …
News

Contract research news in brief

August 18, 2010 Research and Development Anavex, Cyprotex, Synexus

UK contract research organisation Synexus says it is reaping the benefits of its investments in Hungary in recent years, with …
News

Lilly abandons late stage Alzheimer’s drug

August 17, 2010 Research and Development Alzheimer's, lilly

Lilly is to abandon an Alzheimer’s drug in phase III development after results suggested it actually accelerated the disease rather …
News
StemCellPinheadWeb

Regenerative medicine: small steps towards the great leap forward

August 16, 2010 Research and Development GSK, Pfizer, Stem cells, regenerative medicine

Susan Aldridge reports on what some of the leading pharma companies are doing in the regenerative medicine and stem cells …
Feature

Merck signs Alzheimer’s deal with Alectos

August 16, 2010 Research and Development, Sales and Marketing Alzheimer's, Alzheimers, Merck & Co

Merck has entered a $289 million agreement with Canadian company Alectos Therapeutics in a bid to find new Alzheimer’s drugs. …
News
Amgen

Amgen’s Vectibix fails late stage trial

August 12, 2010 Research and Development, Sales and Marketing Amgen, Vectibix, head and neck cancer

Amgen’s potential head and neck cancer treatment Vectibix has failed to meet its primary endpoint of improving overall survival in …
News

Pharminox promotes Dr Marc Hummersone

August 12, 2010 Research and Development Pharminox, appointment, research and development

Nottingham, UK-based cancer drug discovery and development company Pharminox has appointed Dr Marc Hummersone as research director. Marc first joined …
Appointment
The Gateway to Local Adoption Series

Latest content

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 12, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 12, 2026

Cellbox appoints Bernd Muehlenweg as new CBO and CFO

March 12, 2026

Antiverse receive investment from IIC and Development Bank of Wales

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026